We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+20.67%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$302M
(+17%)
Cap. Flow
+$69.4M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
39.8%
Holding
89
New
37
Increased
12
Reduced
15
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$75.2M |
| 2 |
AET
Aetna Inc
AET
|
+$68.6M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$55.8M |
| 4 |
Brookdale Senior Living
BKD
|
+$51.1M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$120M |
| 2 |
Bausch Health
BHC
|
+$93M |
| 3 |
Pfizer
PFE
|
+$76.9M |
| 4 |
Keysight
KEYS
|
+$69M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$60.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.75% |
| 2 | Financials | 3.56% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Gilead Sciences
GILD
$163B
| $6.79M | 0.32% |
69,200
-1,180,800
| -94% | -$120M |
|
52
Accuray
ARAY
$37.2M
| $6.76M | 0.32% |
+727,000
| New | +$5.79M |
|
53
Akebia Therapeutics
AKBA
$351M
| $6.61M | 0.32% |
594,534
-250,720
| -30% | -$2.67M |
|
54
IQVIA
IQV
$38.4B
| $6.46M | 0.31% |
+96,496
| New | +$6.08M |
|
55
Assembly Biosciences
ASMB
$503M
| $6.29M | 0.3% |
+39,583
| New | +$5.36M |
|
56
Sarepta Therapeutics
SRPT
$1.68B
| $6.14M | 0.29% |
+462,700
| New | +$6.17M |
|
57
PUT
Quest Diagnostics
DGX
$25.6B
| $5.76M | 0.28% |
+75,000
| New | +$5.37M |
|
58
Danaher
DHR
$137B
| $5.53M | 0.26% |
96,858
+18,747
| +24% | +$1.08M |
|
59
UnitedHealth
UNH
$370B
| $4.88M | 0.23% |
+41,300
| New | +$4.59M |
|
60
CVS Health
CVS
$133B
| $4.44M | 0.21% |
+43,000
| New | +$4.35M |
|
|
ACGN
61
DELISTED
Aceragen Inc
ACGN
| $4.33M | 0.21% |
8,581
+2,632
| +44% | +$1.6M |
|
62
Cigna
CI
$74.5B
| $4.29M | 0.2% |
+33,159
| New | +$3.85M |
|
|
ELOS
63
DELISTED
Syneron Medical Ltd
ELOS
| $3.26M | 0.16% |
263,400
| – | – |
|
|
ISEE
64
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.6M | 0.08% |
+34,300
| New | +$1.78M |
|
|
LENS
65
DELISTED
Presbia PLC Ordinary Shares
LENS
| $420K | 0.02% |
+56,869
| New | +$417K |
|
|
66
Bausch Health
BHC
$2.62B
| – | – |
-650,000
| Closed | -$93M |
|
67
Cardinal Health
CAH
$55.2B
| – | – |
-385,200
| Closed | -$31.1M |
|
68
Celldex Therapeutics
CLDX
$2.96B
| – | – |
-10,907
| Closed | -$2.99M |
|
69
Intuitive Surgical
ISRG
$130B
| – | – |
-689,400
| Closed | -$40.5M |
|
|
70
Keysight
KEYS
$55B
| – | – |
-2,043,826
| Closed | -$69M |
|
71
McKesson
MCK
$96.8B
| – | – |
-175,600
| Closed | -$36.5M |
|
72
Novavax
NVAX
$1.22B
| – | – |
-32,489
| Closed | -$3.85M |
|
73
Pacira BioSciences
PCRX
$1.06B
| – | – |
-125,000
| Closed | -$11.1M |
|
74
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
| – | – |
-500,000
| Closed | -$34.2M |
|
|
XOMA
75
DELISTED
Xoma
XOMA
| – | – |
-22,500
| Closed | -$1.62M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q1 2015 Portfolio in Review
As of Q1 2015, HealthCor Management held 89 positions worth $2.1B, up 17% from $1.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
HealthCor Management deployed $69.4M of net new capital in Q1 2015, opening 37 new positions and adding to 12 existing holdings. Its largest new stake was Biogen: 190,700 shares worth $80.5M.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 72% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $120M trimmed.
- HealthCor Management's largest Q1 2015 buy was Biogen: 190,700 shares worth $80.5M.
- HealthCor Management added most to Brookdale Senior Living in Q1 2015, an estimated $51.1M increase.
- HealthCor Management's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $120M.
- HealthCor Management fully exited Bausch Health in Q1 2015, selling an estimated $93M.
- HealthCor Management's ten largest holdings make up 40% of its $2.1B portfolio in Q1 2015.
- HealthCor Management opened 37 new positions and closed 24 in Q1 2015.
- HealthCor Management's portfolio value rose 17% quarter-over-quarter to $2.1B.
Based on HealthCor Management's 13F filing for Q1 2015, filed 15 May 2015.